试论WTO的药品知识产权保护对健康权的影响  

On the Impact of Protection of Pharmaceutical Intellectual Property in WTO on Health Rights

作　　者：范文舟[1] 

机构地区：[1]北方民族大学法学院,宁夏银川750021

出　　处：《河北法学》2014年第9期93-98,共6页Hebei Law Science

摘　　要：不论从TRIPs的最低保护标准看,还是从其例外规定看,WTO的药品知识产权保护对健康权影响都具有必然性。因此应建立健康权影响评估机制,要求国家必须评估药品知识产权政策是否限制健康权,及可能受到侵犯的健康权内容为何,评估该药品知识产权政策是否能提供达成目的的最小限制手段,国家必须评估在受限的健康权与药品知识产权所欲构筑的社会秩序(包括经济或社会利益的追求)间,是否有适当的权重关系,以及该权重关系是否具有正当性;等等。Whether by minimum standards of protection in TRIPs or by its Exceptions,protection of pharmaceutical intellectual property in WTO impacts necessarily on health rights. And so, evaluation mechanism should be established about the impact on health rights. By this kind of mechanism, WTO members must assess if policies of pharmaceutical intellectual property restrict health rights, and what kind of content of health rights may be exposed to potential invasions, if policies of pharmaceutical intellectual property can provide the least restrictive means for the purpose achieved, if there are the appropriate weights between health rights restricted and social order （including economic or social benefit pursuit） to be constructed, and if the weights are justified;etc.

关 键 词：国际法 TRIPS 药品知识产权 健康权 评估机制 

分 类 号：D923.4[政治法律—民商法学]